Compare PRFX & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRFX | HTCR |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | Israel | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.3M |
| IPO Year | 2020 | 2022 |
| Metric | PRFX | HTCR |
|---|---|---|
| Price | $0.63 | $1.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 55.4K | 23.3K |
| Earning Date | 09-03-2026 | 11-16-2026 |
| Dividend Yield | N/A | ★ 214.88% |
| EPS Growth | N/A | ★ 414.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,407,229.00 |
| Revenue This Year | N/A | $118.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.19 |
| 52 Week Low | $0.58 | $1.15 |
| 52 Week High | $5.39 | $10.43 |
| Indicator | PRFX | HTCR |
|---|---|---|
| Relative Strength Index (RSI) | 34.85 | 45.35 |
| Support Level | N/A | $1.20 |
| Resistance Level | $1.25 | $1.88 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 5.62 | 33.85 |
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.